Prospective evaluation of the relationship between response and exposure of total and unbound erlotinib in non-small cell lung cancer patients.
Hirotsugu KenmotsuChiyo K ImamuraTakahisa KawamuraTakuya OyakawaShota OmoriKazuhisa NakashimaKazushige WakudaAkira OnoTetsuhiko TairaTateaki NaitoHaruyasu MurakamiNobuyuki YamamotoToshiaki TakahashiYusuke TanigawaraPublished in: Cancer chemotherapy and pharmacology (2022)
UMIN000012862.